Electrocardiographic Abnormalities and Sudden Death in Myotonic Dystrophy Type 1
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Sudden death can occur as a consequence of cardiac-conduction abnormalities in the neuromuscular disease myotonic dystrophy type 1. The determinants of the risk of sudden death remain imprecise. METHODS: We assessed whether the electrocardiogram (ECG) was useful in predicting sudden death in 406 adult patients with genetically confirmed myotonic dystrophy type 1. A patient was characterized as having a severe abnormality if the ECG had at least one of the following features: rhythm other than sinus, PR interval of 240 msec or more, QRS duration of 120 msec or more, or second-degree or third-degree atrioventricular block. RESULTS: Patients with severe abnormalities according to the entry ECG were older than patients without severe abnormalities, had more severe skeletal-muscle impairment, and were more likely to have heart failure, left ventricular systolic dysfunction, or atrial tachyarrhythmia. Such patients were more likely to receive a pacemaker or an implantable cardioverter-defibrillator during the follow-up period. During a mean follow-up period of 5.7 years, 81 patients died; there were 27 sudden deaths, 32 deaths from progressive neuromuscular respiratory failure, 5 nonsudden deaths from cardiac causes, and 17 deaths from other causes. Among the 17 patients who died suddenly in whom postcollapse rhythm was evaluated, a ventricular tachyarrhythmia was observed in 9. A severe ECG abnormality (relative risk, 3.30; 95% confidence interval [CI], 1.24 to 8.78) and a clinical diagnosis of atrial tachyarrhythmia (relative risk, 5.18; 95% CI, 2.28 to 11.77) were independent risk factors for sudden death. CONCLUSIONS: Patients with adult myotonic dystrophy type 1 are at high risk for arrhythmias and sudden death. A severe abnormality on the ECG and a diagnosis of an atrial tachyarrhythmia predict sudden death. (ClinicalTrials.gov number, NCT00622453.)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
The Cardiac Arrhythmia Suppression Trial (CAST) Investigators (1989) · New England Journal of Medicine · doi:10.1056/nejm198908103210629 · Cited by 3,300
Brook, J. D., McCurrach, M. E., Harley, H. G., Buckler, A. J., Church, D., Aburatani, H., Hunter, K., Stanton, V. P., Thirion, J.-P., Hudson, T., et al. (1992) · Cell · doi:10.1016/0092-8674(92)90154-5 · Cited by 2,777
Benjamin, E. J. (1994) · JAMA · doi:10.1001/jama.1994.03510350050036 · Cited by 2,613
An Unstable Triplet Repeat in a Gene Related to Myotonic Muscular Dystrophy
Fu, Y. H., Pizzuti, A., Fenwick, R. G., King, J., Rajnarayan, S., Dunne, P. W., Dubel, J., Nasser, G. A., Ashizawa, T., de Jong, P., et al. (1992) · Science · doi:10.1126/science.1546326 · Cited by 1,455
Gregoratos, G., Abrams, J., Epstein, A. E., Freedman, R. A., Hayes, D. L., Hlatky, M. A., Kerber, R. E., Naccarelli, G. V., Schoenfeld, M. H., Silka, M. J., et al. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02528-7 · Cited by 1,266
Committee Members, Gregoratos, G., Abrams, J., Epstein, A. E., Freedman, R. A., Hayes, D. L., Hlatky, M. A., Kerber, R. E., Naccarelli, G. V., Schoenfeld, M. H., et al. (2002) · Circulation · doi:10.1161/01.cir.0000035996.46455.09 · Cited by 910
Chugh, S. S., Jui, J., Gunson, K., Stecker, E. C., John, B. T., Thompson, B., Ilias, N., Vickers, C., Dogra, V., Daya, M., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.06.029 · Cited by 795
Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy
Buxton, J., Shelbourne, P., Davies, J., Jones, C., Tongeren, T. V., Aslanidis, C., de Jong, P., Jansen, G., Anvret, M., Riley, B., et al. (1992) · Nature · doi:10.1038/355547a0 · Cited by 620
Cloning of the essential myotonic dystrophy region and mapping of the putative defect
Aslanidis, C., Jansen, G., Amemiya, C., Shutler, G., Mahadevan, M., Tsilfidis, C., Chen, C., Alleman, J., Wormskamp, N. G. M., Vooijs, M., et al. (1992) · Nature · doi:10.1038/355548a0 · Cited by 498
A 10-year study of mortality in a cohort of patients with myotonic dystrophy
Mathieu, J., Allard, P., Potvin, L., Prévost, C., & Bégin, P. (1999) · Neurology · doi:10.1212/wnl.52.8.1658 · Cited by 414
Research works printed but not linked: 2
- Florek RC, 1990, West J Med, 153, 24
- 10.1001/jama.271.11.840 · DOI · Paper page
Cited by
Priori, S. G., Blomström-Lundqvist, C., Mazzanti, A., Blom, N., Borggrefe, M., Camm, J., Elliott, P. M., Fitzsimons, D., Hatala, R., Hindricks, G., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv316 · Cited by 3,893
Zeppenfeld, K., Tfelt-Hansen, J., de Riva, M., Winkel, B. G., Behr, E. R., Blom, N. A., Charron, P., Corrado, D., Dagres, N., de Chillou, C., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac262 · Cited by 3,140
2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy
Glikson, M., Nielsen, J. C., Kronborg, M. B., Michowitz, Y., Auricchio, A., Barbash, I. M., Barrabés, J. A., Boriani, G., Braunschweig, F., Brignole, M., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab364 · Cited by 2,019
Al-Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T., Field, M. E., Fonarow, G. C., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.10.054 · Cited by 1,854
(2015) · Europace · doi:10.1093/europace/euv319 · Cited by 1,592
Kusumoto, F. M., Schoenfeld, M. H., Barrett, C., Edgerton, J. R., Ellenbogen, K. A., Gold, M. R., Goldschlager, N. F., Hamilton, R. M., Joglar, J. A., Kim, R. J., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.10.044 · Cited by 1,008
2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy
Glikson, M., Nielsen, J. C., Kronborg, M. B., Michowitz, Y., Auricchio, A., Barbash, I. M., Barrabés, J. A., Boriani, G., Braunschweig, F., Brignole, M., et al. (2022) · EP Europace · doi:10.1093/europace/euab232 · Cited by 914
Goette, A., Kalman, J. M., Aguinaga, L., Akar, J., Cabrera, J. A., Chen, S. A., Chugh, S. S., Corradi, D., D’Avila, A., Dobrev, D., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2016.05.028 · Cited by 771
“The presence of conduction defects and atrial arrhythmias are independent risk factors for sudden death.(103,110) In Emery-Dreifuss and Limb-Girdle type IB disease, widespread atrial fibrosis can lead to atrial standstill.”
Goette, A., Kalman, J. M., Aguinaga, L., Akar, J., Cabrera, J. A., Chen, S. A., Chugh, S. S., Corradi, D., D'Avila, A., Dobrev, D., et al. (2016) · Europace · doi:10.1093/europace/euw161 · Cited by 762
“The presence of conduction defects and atrial arrhythmias are independent risk factors for sudden death.(103,110) In Emery-Dreifuss and Limb-Girdle type IB disease, widespread atrial fibrosis can lead to atrial standstill.”
Al-Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T., Field, M. E., Fonarow, G. C., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000549 · Cited by 724
Al-Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T., Field, M. E., Fonarow, G. C., et al. (2018) · Heart Rhythm · doi:10.1016/j.hrthm.2017.10.035 · Cited by 669
Al-Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T., Field, M. E., Fonarow, G. C., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.10.053 · Cited by 678
Al-Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T., Field, M. E., Fonarow, G. C., et al. (2018) · Heart Rhythm · doi:10.1016/j.hrthm.2017.10.036 · Cited by 629
Kusumoto, F. M., Schoenfeld, M. H., Barrett, C., Edgerton, J. R., Ellenbogen, K. A., Gold, M. R., Goldschlager, N. F., Hamilton, R. M., Joglar, J. A., Kim, R. J., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000628 · Cited by 603
The myotonic dystrophies: molecular, clinical, and therapeutic challenges
Udd, B., & Krahe, R. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70204-1 · Cited by 491
Al-Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T., Field, M. E., Fonarow, G. C., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000548 · Cited by 412
Thornton, C. A. (2014) · Neurologic Clinics · doi:10.1016/j.ncl.2014.04.011 · Cited by 377
Meola, G., & Cardani, R. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.05.019 · Cited by 347
Kusumoto, F. M., Schoenfeld, M. H., Barrett, C., Edgerton, J. R., Ellenbogen, K. A., Gold, M. R., Goldschlager, N. F., Hamilton, R. M., Joglar, J. A., Kim, R. J., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.10.043 · Cited by 337
The myotonic dystrophies: diagnosis and management
Turner, C., & Hilton-Jones, D. (2010) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.158261 · Cited by 329
Feingold, B., Mahle, W. T., Auerbach, S., Clemens, P., Domenighetti, A. A., Jefferies, J. L., Judge, D. P., Lal, A. K., Markham, L. W., Parks, W. J., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000526 · Cited by 306
Steinberg, J. S., Varma, N., Cygankiewicz, I., Aziz, P., Balsam, P., Baranchuk, A., Cantillon, D. J., Dilaveris, P., Dubner, S. J., El-Sherif, N., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.03.038 · Cited by 303
“Myotonic dystrophy is a progressive genetic condition that primarily affects skeletal muscle but has important cardiac complications (Groh et al., 2008).”
BackgroundMisregulation of miR-1 processing is associated with heart defects in myotonic dystrophy
Rau, F., Freyermuth, F., Fugier, C., Villemin, J.-P., Fischer, M.-C., Jost, B., Dembele, D., Gourdon, G., Nicole, A., Duboc, D., et al. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2067 · Cited by 280
Home Mechanical Ventilation: A Canadian Thoracic Society Clinical Practice Guideline
McKim, D. A., Road, J., Avendano, M., Abdool, S., Côté, F., Duguid, N., Fraser, J., Maltais, F., Morrison, D. L., O’Connell, C., et al. (2011) · Canadian Respiratory Journal · doi:10.1155/2011/139769 · Cited by 223
Cardiac involvement in mitochondrial DNA disease: clinical spectrum, diagnosis, and management
Bates, M. G. D., Bourke, J. P., Giordano, C., d'Amati, G., Turnbull, D. M., & Taylor, R. W. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs275 · Cited by 226
“70 ms are high-risk features for sudden death in myotonic dystrophy.(92,93) Recent evidence suggests that an invasive strategy to assess AV conduction in those with high-risk non-invasive features is associated with improved survival.”
BackgroundFreyermuth, F., Rau, F., Kokunai, Y., Linke, T., Sellier, C., Nakamori, M., Kino, Y., Arandel, L., Jollet, A., Thibault, C., et al. (2016) · Nature Communications · doi:10.1038/ncomms11067 · Cited by 204
“Cardiac involvements in DM are characterized by cardiac-conduction delay that may result in fatal atrio-ventricular block, and by atrial or ventricular tachycardia 17,18 .”
InfluentialHereditary muscular dystrophies and the heart
Hermans, M. C. E., Pinto, Y. M., Merkies, I. S. J., de Die-Smulders, C. E. M., Crijns, H. J. G. M., & Faber, C. G. (2010) · Neuromuscular Disorders · doi:10.1016/j.nmd.2010.04.008 · Cited by 195
“However, in lamin A/C carriers and DM1 patients, there is established evidence that pacemakers do not decrease the rates of sudden death, suggesting that lethal tachyarrhythmias contribute to mortality [69,105].”
BackgroundInfluentialMyotonic dystrophy: diagnosis, management and new therapies
Turner, C., & Hilton-Jones, D. (2014) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000128 · Cited by 196
2013 ESC Guidelines on Cardiac Pacing and Cardiac Resynchronization Therapy
(2014) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2013.11.003 · Cited by 196
Compound loss of muscleblind‐like function in myotonic dystrophy
Lee, K., Li, M., Manchanda, M., Batra, R., Charizanis, K., Mohan, A., Warren, S. A., Chamberlain, C. M., Finn, D., Hong, H., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201303275 · Cited by 190
Wahbi, K., Meune, C., Porcher, R., Bécane, H. M., Lazarus, A., Laforêt, P., Stojkovic, T., Béhin, A., Radvanyi-Hoffmann, H., Eymard, B., et al. (2012) · JAMA · doi:10.1001/jama.2012.346 · Cited by 180
“In addition, prophylactic pacing is rarely implemented solely for the first observation of a conduction defect on the electrocardiogram(10) because the estimated ability of the latter to predict sudden death is only approximately 12%.(7) Therefore, a strategy based on an electrophysiological study was proposed to impr…”
BackgroundCardiac manifestations of myotonic dystrophy type 1
Petri, H., Vissing, J., Witting, N., Bundgaard, H., & Køber, L. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.08.037 · Cited by 163
“The myocardial fibrosis probably also relates to the observed systolic ventricular function [3–6].”
BackgroundInfluentialGiudice, J., Xia, Z., Wang, E. T., Scavuzzo, M. A., Ward, A. J., Kalsotra, A., Wang, W., Wehrens, X. H. T., Burge, C. B., Li, W., et al. (2014) · Nature Communications · doi:10.1038/ncomms4603 · Cited by 162
“The alterations in T-tubule structure and function we demonstrated strongly correlate with the finding that eighty percent of individuals with DM1 exhibit cardiac arrhythmias 51 .”
Kamsteeg, E.-J., Kress, W., Catalli, C., Hertz, J. M., Witsch-Baumgartner, M., Buckley, M. F., van Engelen, B. G. M., Schwartz, M., & Scheffer, H. (2012) · European Journal of Human Genetics · doi:10.1038/ejhg.2012.108 · Cited by 160
Kusumoto, F. M., Schoenfeld, M. H., Barrett, C., Edgerton, J. R., Ellenbogen, K. A., Gold, M. R., Goldschlager, N. F., Hamilton, R. M., Joglar, J. A., Kim, R. J., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000627 · Cited by 160
Shah, M. J., Silka, M. J., Silva, J. N. A., Balaji, S., Beach, C. M., Benjamin, M. N., Berul, C. I., Cannon, B. C., Cecchin, F., Cohen, M. I., et al. (2021) · Heart Rhythm · doi:10.1016/j.hrthm.2021.07.038 · Cited by 170
Koshelev, M., Sarma, S., Price, R. E., Wehrens, X. H. T., & Cooper, T. A. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddp570 · Cited by 151
CUGBP1 overexpression in mouse skeletal muscle reproduces features of myotonic dystrophy type 1
Ward, A. J., Rimer, M., Killian, J. M., Dowling, J. J., & Cooper, T. A. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq277 · Cited by 182
Goette, A., Kalman, J. M., Aguinaga, L., Akar, J. G., Cabrera, J. Á., Chen, S. A., Chugh, S. S., Corradi, D., d’Ávila, A., Dobrev, D., et al. (2016) · Journal of Arrhythmia · doi:10.1016/j.joa.2016.05.002 · Cited by 164
“arrhythmias are independent risk factors for sudden death [103,110].”
An Overview of Alternative Splicing Defects Implicated in Myotonic Dystrophy Type I
López‐Martínez, A., Soblechero‐Martín, P., Ovejero, L. D. L. P., Nogales‐Gadea, G., & Arechavala‐Gomeza, V. (2020) · Genes · doi:10.3390/genes11091109 · Cited by 150
Kusumoto, F. M., Schoenfeld, M. H., Barrett, C., Edgerton, J. R., Ellenbogen, K. A., Gold, M. R., Goldschlager, N., Hamilton, R. M., Joglar, J. A., Kim, R. J., et al. (2018) · Heart Rhythm · doi:10.1016/j.hrthm.2018.10.036 · Cited by 142
Kusumoto, F. M., Schoenfeld, M. H., Barrett, C., Edgerton, J. R., Ellenbogen, K. A., Gold, M. R., Goldschlager, N. F., Hamilton, R. M., Joglar, J. A., Kim, R. J., et al. (2019) · Heart Rhythm · doi:10.1016/j.hrthm.2018.10.037 · Cited by 131
MicroRNA regulation of cardiac conduction and arrhythmias
Kim, G. H. (2012) · Translational research · doi:10.1016/j.trsl.2012.12.004 · Cited by 140
“Furthermore, individuals with myotonic dystrophy are also characterized by atrial and ventricular tachyarrythmias (39).”
BackgroundArrhythmias in the muscular dystrophies
Groh, W. J. (2012) · Heart Rhythm · doi:10.1016/j.hrthm.2012.06.038 · Cited by 135
Self-citationPandey, S., Wheeler, T. M., Justice, S. L., Kim, A., Younis, H. S., Gattis, D., Jauvin, D., Puymirat, J., Swayze, E. E., Freier, S. M., et al. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.226969 · Cited by 131
Steinberg, J. S., Varma, N., Cygankiewicz, I., Aziz, P. F., Balsam, P., Baranchuk, A. M., Cantillon, D. J., Dilaveris, P., Dubner, S., El‐Sherif, N., et al. (2017) · Annals of Noninvasive Electrocardiology · doi:10.1111/anec.12447 · Cited by 131
“Myotonic dystrophy is a progressive genetic condition that primarily affects skeletal muscle but has important cardiac complications (Groh et al., 2008).”
BackgroundTada, M., Kakita, A., Toyoshima, Y., Onodera, O., Ozawa, T., Morita, T., Nishizawa, M., & Takahashi, H. (2009) · Brain · doi:10.1093/brain/awp110 · Cited by 118
Aortic pulse wave velocity predicts mortality in chronic kidney disease stages 2–4
Baumann, M., Wassertheurer, S., Suttmann, Y., Burkhardt, K., & Heemann, U. W. (2014) · Journal of Hypertension · doi:10.1097/hjh.0000000000000113 · Cited by 120
PKC inhibition ameliorates the cardiac phenotype in a mouse model of myotonic dystrophy type 1
Wang, G., Kuyumcu‐Martinez, M. N., Sarma, S., Mathur, N., Wehrens, X. H. T., & Cooper, T. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37976 · Cited by 141
Cardiac Phenotypes in Hereditary Muscle Disorders
Arbustini, E., Toro, A. D., Giuliani, L., Favalli, V., Narula, N., & Grasso, M. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.08.2182 · Cited by 114
Diagnostic odyssey of patients with myotonic dystrophy
Hilbert, J. E., Ashizawa, T., Day, J., Luebbe, E. A., Martens, W. B., McDermott, M., Tawil, R., Thornton, C. A., & Moxley, R. T. (2013) · Journal of Neurology · doi:10.1007/s00415-013-6993-0 · Cited by 100
Causes and place of death in Italian patients with amyotrophic lateral sclerosis
Spataro, R., Re, M. L., Piccoli, T., Piccoli, F., & Bella, V. L. (2010) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2009.01290.x · Cited by 110
“Sudden death was defined as death occurring suddenly and unexpectedly in patients who had been stable before the event (13).”
BackgroundMuscle wasting in myotonic dystrophies: a model of premature aging
Mateos-Aierdi, A. J., Goicoechea, M., Aiastui, A., Fernández‐Torrón, R., García-Puga, M., Matheu, A., & de Munaín, A. L. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00125 · Cited by 117
“Different trends of these modifications have been associated with aging, such as increased histone H4K16 acetylation, H4K20 trimethylation and H3K4 trimethylation, and decreased H3K9 methylation or H3K27 trimethylation (Fraga and Esteller, 2007; Han and Brunet, 2012; López-Otín et al., 2013).”
BackgroundKalsotra, A., Singh, R. K., Gurha, P., Ward, A. J., Creighton, C. J., & Cooper, T. A. (2014) · Cell Reports · doi:10.1016/j.celrep.2013.12.025 · Cited by 117
“More than 80% of individuals affected with DM1 have cardiac conduction defects and arrhythmias, and a lower percentage are affected by interstitial fibrosis and dilated cardiomyopathy (Groh et al., 2008; Lazarus et al., 2002; Nazarian et al., 2010; Pelargonio et al., 2002; Phillips and Harper, 1997; Sovari et al., 200…”
BackgroundInfluentialBHAKTA, D., SHEN, C., KRON, J., EPSTEIN, A. E., PASCUZZI, R. M., & GROH, W. J. (2011) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2011.02200.x · Cited by 94
Self-citationBhakta, D., Groh, M. R., Shen, C., Pascuzzi, R. M., & Groh, W. J. (2010) · American Heart Journal · doi:10.1016/j.ahj.2010.07.032 · Cited by 89
Self-citationJohnson, N. E. (2019) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000793 · Cited by 90
Myotonic dystrophy and the heart: A systematic review of evaluation and management
Lau, J. K., Sy, R. W., Corbett, A., & Kritharides, L. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.03.069 · Cited by 97
Loss of muscleblind-like 1 results in cardiac pathology and persistence of embryonic splice isoforms
Dixon, D. M., Choi, J., El‐Ghazali, A., Park, S. Y., Roos, K. P., Jordan, M. C., Fishbein, M. C., Comai, L., & Reddy, S. (2015) · Scientific Reports · doi:10.1038/srep09042 · Cited by 100
“Significantly, QRS widening is known to greatly increase the chance of sudden death in the general human population with cardiomyopathy and in DM1 patients 11,12,65 .”
Wahbi, K., Babuty, D., Probst, V., Wissocque, L., Labombarda, F., Porcher, R., Bécane, H. M., Lazarus, A., Béhin, A., Laforêt, P., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw569 · Cited by 98
Ventricular arrhythmias. Ventricular tachycardias and sudden cardiac death. 2020 Clinical guidelines
Lebedev, D. S., Mikhaylov, E. N., Neminuschiy, N. M., Golukhova, E. Z., Babokin, V. E., Bereznitskaya, V. V., Vasichkina, E. S., Garkina, S. V., Sp, G., Davtyan, K. V., et al. (2021) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2021-4600 · Cited by 96
Survival and CTG repeat expansion in adults with myotonic dystrophy type 1
Groh, W. J., Groh, M. R., Shen, C., Monckton, D. G., Bodkin, C. L., & Pascuzzi, R. M. (2011) · Muscle & Nerve · doi:10.1002/mus.21934 · Cited by 75
Self-citationMortality in myotonic dystrophy patients in the area of prophylactic pacing devices
Laurent, V., Pellieux, S., Corcia, P., Magro, P., Pierre, B., Fauchier, L., Raynaud, M., & Babuty, D. (2010) · International Journal of Cardiology · doi:10.1016/j.ijcard.2010.02.029 · Cited by 74
Hermans, M. C. E., Faber, C. G., Bekkers, S. C. A. M., de Die-Smulders, C. E. M., Gerrits, M. M., Merkies, I. S. J., Snoep, G., Pinto, Y. M., & Schalla, S. M. (2012) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/1532-429x-14-48 · Cited by 74
Oral administration of erythromycin decreases RNA toxicity in myotonic dystrophy
Nakamori, M., Taylor, K., Mochizuki, H., Sobczak, K., & Takahashi, M. P. (2015) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.271 · Cited by 90
“Cardiac conduction abnormalities are critical symptoms in DM1, sometimes leading to sudden death.(40) Although the major manifestation is prolongation of the PR interval and QRS duration, several studies report a prolonged QT interval in DM1.”
BackgroundCongenital and infantile myotonic dystrophy
Échenne, B., & Bassez, G. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-444-59565-2.00009-5 · Cited by 76
Shah, M. J., Silka, M. J., Silva, J. N. A., Balaji, S., Beach, C. M., Benjamin, M. N., Berul, C. I., Cannon, B. C., Cecchin, F., Cohen, M. I., et al. (2021) · Cardiology in the Young · doi:10.1017/s1047951121003413 · Cited by 87
Groh, W. J., Bhakta, D., Tomaselli, G. F., Aleong, R. G., Teixeira, R. A., Amato, A. A., Asirvatham, S. J., Cha, Y., Corrado, D., Duboc, D., et al. (2022) · Heart Rhythm · doi:10.1016/j.hrthm.2022.04.022 · Cited by 78
Self-citationMyotonic Dystrophy Type 1 Management and Therapeutics
Smith, C. A., & Gutmann, L. (2016) · Current Treatment Options in Neurology · doi:10.1007/s11940-016-0434-1 · Cited by 84
Severe infantile-onset cardiomyopathy associated with a homozygous deletion in desmin
Piñol‐Ripoll, G., Shatunov, A., Cabello, A., Larrodé, P., de la Puerta, I., Pelegrín, J., Ramos, F. J., Olivé, M., & Goldfarb, L. G. (2009) · Neuromuscular Disorders · doi:10.1016/j.nmd.2009.04.004 · Cited by 68
“Ventricular arrhythmias have also been documented as an associated sign in several inherited myopathies including myotonic dystrophy [15] and laminopathy [16].”
Mexiletine in Myotonic Dystrophy Type 1
Heatwole, C. R., Luebbe, E. A., Rosero, S. Z., Eichinger, K. J., Martens, W. B., Hilbert, J. E., Dekdebrun, J. M., Dilek, N., Zizzi, C. E., Johnson, N. E., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000011002 · Cited by 67
Cardiac involvement in myotonic dystrophy: a nationwide cohort study
Lund, M., Díaz, L. J., Ranthe, M. F., Petri, H., Dunø, M., Juncker, I., Eiberg, H., Vissing, J., Bundgaard, H., Wohlfahrt, J., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu157 · Cited by 67
“The positive predictived value of a myotonic dystrophy diagnosis in the National Patient Registry representing a DM1 patient was 395/(395 + 79) ¼ 83%, i.e. overall an estimated (0.83 × 692 + 1.0 × 494)/1146 ¼ 93% of the main study cohort had DM1. cThe 494 DM1 patients constitute the total number of patients geneticall…”
InfluentialMechanisms and management of the heart in myotonic dystrophy
McNally, E. M., & Sparano, D. (2011) · Heart · doi:10.1136/hrt.2010.214197 · Cited by 67
“Muscular dystrophy is a genetically diverse group of disorders that can affect both children and adults. Many forms of muscular dystrophy have significant cardiac manifestations. The most common cardiac consequences in muscular dystrophy are cardiomyopathy and arrhythmias. Correct identification of the genetic subtype…”
BackgroundSansone, V., Brigonzi, E., Schoser, B. G. H., Villani, S., Gaeta, M., Ambroggi, G. D., Bandera, F., AMBROGGI, L. D., & Meola, G. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.11.076 · Cited by 65
“While cardiac involvement is well documented in DM1 [1–15] and predictors of AV conduction disturbances, cardiac arrhythmias and sudden death are being defined in DM1 [4,16–21] there are still limited data in DM2 [22–26].”
BackgroundResultInfluentialPetri, H., Witting, N., Ersbøll, M. K., Sajadieh, A., Dunø, M., Helweg‐Larsen, S., Vissing, J., Køber, L., & Bundgaard, H. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.03.088 · Cited by 72
Brugada syndrome and abnormal splicing of SCN5A in myotonic dystrophy type 1
Wahbi, K., Algalarrondo, V., Bécane, H. M., Fressart, V., Beldjord, C., Azibi, K., Lazarus, A., Berber, N., Radvanyi, H., Stojkovic, T., et al. (2013) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2013.08.003 · Cited by 68
Clinical Care Recommendations for Cardiologists Treating Adults With Myotonic Dystrophy
McNally, E. M., Mann, D. L., Pinto, Y. M., Bhakta, D., Tomaselli, G. F., Nazarian, S., Groh, W. J., Tamura, T., Duboc, D., Itoh, H., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.014006 · Cited by 63
“Data are lacking as to whether aspirin is beneficial in DM.”
BackgroundInfluentialSelf-citationRisk of arrhythmia in type I myotonic dystrophy: the role of clinical and genetic variables
Cudia, P., Bernasconi, P., Chiodelli, R., Mangiola, F., Bellocci, F., Russo, A. D., Angelini, C. I., Romeo, V., Melacini, P., Politano, L., et al. (2009) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.162594 · Cited by 60
“and that cardioverter defibrillators that can treat both bradycardia and tachyarrhythmias may be beneficial in preventing sudden death.(7) The development and the rate of progression of arrhythmias are unpredictable.”
BackgroundMolecular and genetic insights into progressive cardiac conduction disease
Asatryan, B., & Medeiros‐Domingo, A. (2019) · EP Europace · doi:10.1093/europace/euz109 · Cited by 62
Carrell, S., Carrell, E. M., Auerbach, D. S., Pandey, S., Bennett, C. F., Dirksen, R. T., & Thornton, C. A. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw266 · Cited by 71
Antoury, L., Hu, N., Balaj, L., Das, S., Georghiou, S., Darras, B. T., Clark, T., Breakefield, X. O., & Wheeler, T. M. (2018) · Nature Communications · doi:10.1038/s41467-018-06206-0 · Cited by 57
Molecular functions and specific roles of circRNAs in the cardiovascular system
Holdt, L. M., Kohlmaier, A., & Teupser, D. (2018) · Non-coding RNA Research · doi:10.1016/j.ncrna.2018.05.002 · Cited by 56
Petri, H., Ahtarovski, K. A., Vejlstrup, N. G., Vissing, J., Witting, N., Køber, L., & Bundgaard, H. (2014) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/preaccept-1991790702125713 · Cited by 55
HA, A. H., TARNOPOLSKY, M. A., BERGSTRA, T. G., NAIR, G. M., AL‐QUBBANY, A., & HEALEY, J. S. (2012) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2012.03351.x · Cited by 54
“Patients are offered pacemaker implantation if they have: (1) Documented second degree (any type at any time of the day) or third-degree AV block, with or without symptoms; (2) Syncope or unexplained presyncope (other than typical vasovagal) in the presence of any conduction disturbance, including a PR-interval of ≥20…”
MethodSelf-citationAltered MEF2 isoforms in myotonic dystrophy and other neuromuscular disorders
Bachinski, L. L., Sirito, M., Böhme, M., Baggerly, K., Udd, B., & Krahe, R. (2010) · Muscle & Nerve · doi:10.1002/mus.21789 · Cited by 58
Johnson, N. E., Ekström, A., Campbell, C., Hung, M., Adams, H., Chen, W., Luebbe, E. A., Hilbert, J. E., Moxley, R. T., & Heatwole, C. R. (2015) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.12948 · Cited by 55
Wicklund, M. (2013) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000440659.41675.8b · Cited by 51
Organ Dysfunction and Muscular Disability in Myotonic Dystrophy Type 1
Kaminsky, P., Poussel, M., Pruna, L., Deibener, J., Chenuel, B. J., & Brembilla-Perrot, B. (2011) · Medicine · doi:10.1097/md.0b013e318226046b · Cited by 51
Brembilla-Perrot, B., Schwartz, J., Huttin, O., Frikha, Z., Sellal, J., Sadoul, N., Blangy, H., Olivier, A., Léonard-Louis, S., & Kaminsky, P. (2013) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.12260 · Cited by 53
Shah, M. J., Silka, M. J., Silva, J. N. A., Balaji, S., Beach, C. M., Benjamin, M. N., Berul, C. I., Cannon, B. C., Cecchin, F., Cohen, M. I., et al. (2021) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2021.07.009 · Cited by 58
Sudden cardiac death in neuromuscular disorders
Finsterer, J., Stöllberger, C., & Maeztu, C. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.10.176 · Cited by 48
Cardiac Involvement in Myotonic Dystrophy Type 2 Patients With Preserved Ejection Fraction
Schmacht, L. M., Traber, J., Grieben, U. I., Utz, W., Dieringer, M. A., Kellman, P., Błaszczyk, E., von Knobelsdorff‐Brenkenhoff, F., Spuler, S., & Schulz‐Menger, J. (2016) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.115.004615 · Cited by 48
“We evaluated the 12-lead ECGs using the Groh criteria.(30) Patients were ranked positive if one of the following criteria was present: no sinus rhythm, PR interval of ≥240 ms, QRS duration of ≥120 ms, and second- or third-degree atrioventricular block.”
InfluentialCardiovascular manifestations of myotonic dystrophy
Wahbi, K., & Furling, D. (2019) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2019.06.001 · Cited by 48
“[20] Groh WJ , Groh MR , Saha C , Kincaid JC , Simmons Z , Ciafaloni E , et al.”
BackgroundInfluentialBenichou, S. A., Jauvin, D., Serres‐Bérard, T. D., Pierre, M., Ling, K., Bennett, C. F., Rigo, F., Gourdon, G., Chahine, M., & Puymirat, J. (2022) · Gene Therapy · doi:10.1038/s41434-022-00316-7 · Cited by 55
“DM1 is an autosomal dominant disease associated not only with progressive muscle weakness and myotonia but also with broad clinical features, including cardiac involvement, endocrine deficiencies, and central nervous system (CNS) alterations [1, 3, 4].”
BackgroundThe Dystrophic and Nondystrophic Myotonias
Sansone, V. (2016) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000414 · Cited by 49
Misra, C., Bangru, S., Lin, F., Lam, K. L. H., Koenig, S. N., Lubbers, E. R., Hedhli, J., Murphy, N. P., Parker, D. J., Dobrucki, L. W., et al. (2020) · Developmental Cell · doi:10.1016/j.devcel.2020.01.037 · Cited by 58
“More than twothirds of DM1 individuals experience severe heart dysfunctions including cardiacconduction delay, fatal sinoatrial and atrioventricular blocks, atrial fibrillation, and ventricular arrhythmias (Groh et al., 2008; Lazarus et al., 2002; Tokgozoglu et al., 1995).”
BackgroundEpigenetic modifications in trinucleotide repeat diseases
Evans‐Galea, M. V., Hannan, A. J., Carrodus, N. L., Delatycki, M. B., & Saffery, R. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.07.007 · Cited by 54
Boussaïd, G., Lofaso, F., Santos, D. B., Vaugier, I., Pottier, S., Prigent, H., Orlikowski, D., & Bahrami, S. (2016) · Neuromuscular Disorders · doi:10.1016/j.nmd.2016.07.014 · Cited by 44
Orthopaedic Manifestations of Congenital Myotonic Dystrophy During Childhood and Adolescence
Canavese, F., & Sussman, M. D. (2009) · Journal of Pediatric Orthopaedics · doi:10.1097/bpo.0b013e3181982bf6 · Cited by 43
Risk of Arrhythmias in MYotonic Dystrophy: trial design of the RAMYD study
Russo, A. D., Mangiola, F., Bella, P. E. D., Nigro, G., Melacini, P., Bongiorni, M. G., Tondo, C., Calò, L., Messano, L., Pace, M., et al. (2009) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e328319bd2c · Cited by 43
Metadata
- Authors
- Groh, W. J., Groh, M. R., Saha, C., Kincaid, J. C., Simmons, Z., Ciafaloni, E., Pourmand, R., Otten, R. F., Bhakta, D., Nair, G. V., Marashdeh, M. M., Zipes, D. P., & Pascuzzi, R. M.
- Affiliations
- Indiana University Indianapolis (US)
- Pennsylvania State University (US)
- University of Rochester Medicine (US)
- State University of New York (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2008-06-19
- Volume
- 358
- Issue
- 25
- Pages
- 2688-2697
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2083028245
- Cited by
- 511
- References
- 32
- Citations by year
- 2026: 19 · 2025: 21 · 2024: 19 · 2023: 22 · 2022: 26 · 2021: 30 · 2020: 34 · 2019: 31 · 2018: 36 · 2017: 39 · 2016: 34 · 2015: 28 · 2014: 32 · 2013: 20 · 2012: 32
- FWCI
- 20.88
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Center for Research Resources (MO1 RR00750-27S1, M01RR000750)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
- Keywords
- myotonic dystrophy type 1, sudden death, electrocardiographic abnormalities, atrial tachyarrhythmia, ventricular tachyarrhythmia, cardiac conduction disorders, atrioventricular block, risk factors, implantable cardioverter-defibrillator, cardiac pacemaker, neuromuscular disorders
- MeSH terms
- Adult, Arrhythmias, Cardiac, Cause of Death, Electrocardiography, Female, Follow-Up Studies, Humans, Male, Middle Aged, Myotonic Dystrophy, Prognosis, Risk Factors, Tachycardia, Death, Sudden, Cardiac
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.